Benjamin Wu is Director at Bone Biologics Corp (NONE). They have made 2 open-market trades across 2 companies since 2015, most recently 2015-12-22.
CIK 0001656584
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BBLG | 970,991 | $427K |
| PrivateUnlisted | 973,628 | — |
| Total | $427K |
Shares reported on the most recent Form 4, priced at the 2016-03-11 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BBLG | SELL | 2015-12-22 | 2016-03-11 | $1.58 | $4K | -5.3% | +7.2% | +7.2% |
| PrivateBone Biologics Corp | SELL | 2015-10-09 | 2015-12-21 | $1.58 | $42K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.